FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/6/2026
Oppenheimer analyst Steven Lichtman raised the price target on DexCom (NASDAQ: DXCM) to $150.00 (from $125.00) while maintaining a Outperform rating.
The analyst commented, "DXCM's 3Q18 sales of $267M (+45% cc) beat our/consensus' $241/$243M, led by strong outperformance in International and better... More
Stephens analyst Chris Cooley raised the price target on DexCom (NASDAQ: DXCM) to $170.00 (from $160.00) while maintaining a Overweight rating following the company's 3Q report. Sales were in-line with Stephens' well-above consensus revenue estimate.
DXCM appears well positioned to continue to deliver... More

